ACC: Fish Oil Does Not Improve Outcomes for Those at High CV Risk
Patients with the highest levels of EPA had similar rates of major adverse cardiovascular events as patients taking placebo
Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
Two replicate double-blind, randomized, placebo-controlled trials show short-term efficacy for upadacitinib in adolescents and adults
Approved Vaccines ‘Respond’ to All COVID-19 Variants So Far: WHO
However, unknown variants of the virus could still emerge and be resistant to existing vaccines
CDC: Self-Administered Subcutaneous DMPA Should Be Made Available
WHO recommendation adopted based on evidence that self-administered DMPA-SC is safe, effective with higher continuation rates
Physician’s Briefing Weekly Coronavirus Roundup
More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy
Meds Used for Hospitalized COVID-19 Patients Shifted Over 2020
Dexamethasone and remdesivir use grew substantially, while azithromycin and hydroxychloroquine both declined from early peaks
COVID-19 Pandemic Tied to Increase in Overdose Deaths
Weekly median overdose deaths increased by 50 percent after stay-at-home order
Presentation of Multisystem Inflammatory Syndrome Varies in Adults
60 percent of patients with MIS-A had acute COVID-19 symptoms, 20 percent were admitted for COVID-19 before being admitted for MIS-A
Key Factors ID’d for Bipolar Medication Nonadherence
Patients report side effects, beliefs, and knowledge about bipolar disorder are top reasons for not taking medications
